Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

More research is needed to understand how testosterone is maintained in adult males.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Genes and hormones cause hair loss, with four genes contributing equally.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

There is no significant link between male pattern baldness and insulin resistance.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.

Some supplements and hormones can increase hair loss by raising DHT levels.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.